|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 307/26 | (2006.01) |
| C07D 493/04 | (2006.01) |
| (11) | Number of the document | 1532127 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03762054.9 |
| Date of filing the European patent application | 2003-06-25 | |
| (97) | Date of publication of the European application | 2005-05-25 |
| (45) | Date of publication and mention of the grant of the patent | 2006-09-27 |
| (46) | Date of publication of the claims translation | 2007-02-26 |
| (86) | Number | PCT/US2003/020094 |
| Date | 2003-06-25 |
| (87) | Number | WO 2004/002975 |
| Date | 2004-01-08 |
| (30) | Number | Date | Country code |
| 392677 P | 2002-06-27 | US |
| (72) |
DOAN, Brian, Daniel GlaxoSmithKline, US
PATTERSON, Daniel, Edward GlaxoSmithKline, US
ROBERTS, John, C. GlaxoSmithKline, US
|
| (73) |
SMITHKLINE BEECHAM CORPORATION,
One Franklin Plaza P.O. Box 7929, Philadelphia, PA 19101,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | (3Alfa, 3alfa/beta, 6alfa/beta)heksahidrofuro(2,3-b)furan-3-olio stereoizomerų gavimas |
| PREPARATION OF STEREOISOMERS OF (3ALPHA, 3ALPHA/BETA, 6ALPHA/BETA) HEXAHYDROFURO(2,3-b) FURAN-3-OL |
| Payment date | Validity (years) | Amount | |
| 2008-05-12 | 6 | 480.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2009-06-25 |